{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:20:30Z","timestamp":1774509630695,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.forsciint.2016.06.026","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T15:22:02Z","timestamp":1466868122000},"page":"343-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The relationship between bupropion and suicide in post-mortem investigations"],"prefix":"10.1016","volume":"266","author":[{"given":"Pirkko","family":"Kriikku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2016.06.026_bib0235","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2005.01.027","article-title":"Bupropion XL in adults with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled study","volume":"57","author":"Wilens","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0240","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","article-title":"Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors","volume":"60","author":"Papakostas","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0245","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biopsych.2004.05.009","article-title":"Treatment of cocaine dependence and depression","volume":"56","author":"Rounsaville","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4088\/PCC.v07n0305","article-title":"15 Years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL","volume":"7","author":"Fava","year":"2005","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0255","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/j.1552-4604.1997.tb04361.x","article-title":"Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers","volume":"37","author":"Hsyu","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00007691-198512000-00015","article-title":"Stability of bupropion and its major metabolites in human plasma","volume":"7","author":"Laizure","year":"1985","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0265","first-page":"381","article-title":"Liquid chromatography tandem mass spectrometry method for quantification of buproprion and hydroxy buproprion in human plasma and its application to bioequivalence study","volume":"4","author":"Jain","year":"2012","journal-title":"Int. J. Drug Dev. Res."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0270","unstructured":"Prescribing Information of Wellbutrin, Glaxo Wellcome, 2012, available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018644s045,020358s052lbl.pdf (accessed 04.12.15)."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-200262002-00002","article-title":"Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation","volume":"62","author":"Johnston","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0280","first-page":"206","article-title":"Bupropion: clinical assay for amphetamine-like abuse potential","volume":"44","author":"Griffith","year":"1983","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000075550","article-title":"Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting","volume":"70","author":"Zernig","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0290","doi-asserted-by":"crossref","DOI":"10.1046\/j.0306-5251.2001.01538.x","article-title":"Recreational bupropion abuse in a teenager","volume":"53","author":"McCormick","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0295","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/JCP.0b013e3181c09475","article-title":"Abuse potential of bupropion nasal insufflation: a case report","volume":"29","author":"Langguth","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1017\/S1481803500012203","article-title":"Seizures induced by recreational abuse of bupropion tablets via nasal insufflation","volume":"12","author":"Kim","year":"2010","journal-title":"CJEM"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10884602.2011.647838","article-title":"Wellbutrin\u00ae: misuse and abuse by incarcerated individuals","volume":"23","author":"Phillips","year":"2012","journal-title":"J. Addict. Nurs."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0310","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JCP.0b013e318295fe2f","article-title":"Additional evidence of the abuse potential of bupropion","volume":"33","author":"Reeves","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0315","doi-asserted-by":"crossref","DOI":"10.1111\/j.1521-0391.2013.00329.x","article-title":"Intranasal bupropion abuse","volume":"22","author":"Yoon","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0320","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ADM.0000000000000044","article-title":"Intravenous administration and abuse of bupropion: a case report and a review of the literature","volume":"8","author":"Oppek","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0325","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1503\/cmaj.131534","article-title":"Bupropion abuse and overdose","volume":"186","author":"Stall","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0330","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/ajad.12308","article-title":"Bupropion abuse resulting in hypomania in a geriatric amphetamine user: a case report","volume":"24","author":"Rostas","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0335","series-title":"Health at a Glance 2013: OECD Indicators","author":"Organisation of Economic Co-operation and Development","year":"2013"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(97)06364-2","article-title":"Predictors of suicide, accidental death, and premature natural death in a general-population birth cohort","volume":"351","author":"Neeleman","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0345","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pam.20089","article-title":"Anti-depressants, suicide, and drug regulation","volume":"24","author":"Ludwig","year":"2005","journal-title":"J. Policy Anal. Manag."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0350","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.62.2.165","article-title":"The relationship between antidepressant medication use and rate of suicide","volume":"62","author":"Gibbons","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0355","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/pds.618","article-title":"Antidepressant medication and suicide in Sweden","volume":"10","author":"Carlsten","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.163.1.41","article-title":"Suicide risk during antidepressant treatment","volume":"163","author":"Simon","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0365","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0447.1997.tb10147.x","article-title":"Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981\u20131992","volume":"96","author":"Fugelstad","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2006.08.002","article-title":"Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002\u20132003","volume":"169","author":"J\u00f6nsson","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0375","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2014.04.017","article-title":"A 3-year review of new psychoactive substances in casework","volume":"243","author":"Elliott","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0380","first-page":"1","article-title":"The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland","author":"Kriikku","year":"2015","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0385","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research: FDA public health advisory: Worsening depression and suicidality in patients being treated with antidepressant medications, March 22, 2004. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm161696.htm (accessed 02.06.16)."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0390","article-title":"The smoking cessation aids varenicline (marketed as Chantix) and bupropion (marketed as Zyban and generics): suicidal ideation and behavior","volume":"2","author":"US Food and Drug Administration","year":"2009","journal-title":"Drug Safety Newsletter (FDA)"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0395","unstructured":"Act of the inquest into the cause of death (Laki kuolemansyyn selvitt\u00e4misest\u00e4 459\/1973)."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0400","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1007\/s00216-013-7272-8","article-title":"A high-sensitivity ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine","volume":"405","author":"Sundstr\u00f6m","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/dta.1818","article-title":"Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS","volume":"8","author":"Sundstr\u00f6m","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0410","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1570-0232(02)01012-7","article-title":"Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood","volume":"788","author":"Rasanen","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0415","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/ip.2006.012922","article-title":"Surveillance of injury-related deaths: medicolegal autopsy rates and trends in Finland","volume":"13","author":"Lunetta","year":"2007","journal-title":"Inj. Prev."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0420","first-page":"3263","article-title":"My\u00f6s masennusl\u00e4\u00e4kkeit\u00e4 v\u00e4\u00e4rink\u00e4ytet\u00e4\u00e4n (Antidepressant are also being abused)","volume":"48","author":"Heikman","year":"2015","journal-title":"Suomen L\u00e4\u00e4k\u00e4rilehti"},{"key":"10.1016\/j.forsciint.2016.06.026_bib0425","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12024-007-0030-5","article-title":"Fatal bupropion overdose with post mortem blood concentrations","volume":"4","author":"Spiller","year":"2008","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0430","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jat\/16.5.343","article-title":"Tissue distribution of bupropion in a fatal overdose","volume":"16","author":"Rohrig","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0379-0738(92)90173-T","article-title":"Bupropion and alcohol fatal intoxication: case report","volume":"56","author":"Ramcharitar","year":"1992","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0440","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jat\/17.7.436","article-title":"Three fatal drug overdoses involving bupropion","volume":"17","author":"Friel","year":"1993","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0445","first-page":"321","article-title":"Fatal bupropion overdose","volume":"35","author":"Harris","year":"1997","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0450","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0736-4679(02)00522-X","article-title":"Bupropion exposures: clinical manifestations and medical outcome","volume":"23","author":"Belson","year":"2002","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0455","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpba.2010.04.024","article-title":"The aqueous stability of bupropion","volume":"53","author":"O\u2019Byrne","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2016.06.026_bib0460","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","article-title":"Bupropion for major depressive disorder: pharmacokinetic and formulation considerations","volume":"27","author":"Jefferson","year":"2005","journal-title":"Clin. Ther."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381630278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381630278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T14:07:20Z","timestamp":1572703640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037907381630278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":46,"alternative-id":["S037907381630278X"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2016.06.026","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between bupropion and suicide in post-mortem investigations","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2016.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}